PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION

Influenza is an acute respiratory viral infection, which represents an important health problem. Every year, influenza causes epidemics and pandemics, leading to increase in morbidity and mortality in all regions of the globe. Due to the segmental organization of the genome and low accuracy of it...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	V. V. Zarubaev, S. V. Vasilieva, Y. L. Esaulkova, A. V. Garshinina, V. M. Veprintseva, A. V. Galochkina, Y. S. Protsak, I. V. Teselkin, A. S. Morkovnik, L. N. Divaeva, I. N. Lavrentieva
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	influenza influenza infection chemotherapy benzimidazole derivatives antivirals activity in vivo. Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/937dc81199dd4829af7c81afc3581a49
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:937dc81199dd4829af7c81afc3581a49
record_format	dspace
spelling	oai:doaj.org-article:937dc81199dd4829af7c81afc3581a492021-11-22T07:09:49ZPROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION2220-76192313-739810.15789/2220-7619-2018-2-195-200https://doaj.org/article/937dc81199dd4829af7c81afc3581a492018-09-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/738https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Influenza is an acute respiratory viral infection, which represents an important health problem. Every year, influenza causes epidemics and pandemics, leading to increase in morbidity and mortality in all regions of the globe. Due to the segmental organization of the genome and low accuracy of its replication, the influenza virus is capable of escaping the host’s immune response (antigenic drift), as well as the selection of drug-resistant variants. This calls for constant monitoring of the sensitivity of viral isolates to antiviral drugs and the development of new etiotropic antiviral agents that have alternative targets and mechanisms of activity. The purpose of this study was to characterize the new aminobenzimidazole derivatives as protective agents in lethal influenza infection in white mice. The efficacy of the compounds was assessed by their ability to reduce specific mortality of animals in the course of lethal influenza pneumonia caused by the influenza A/Puerto Rico/8/34 (H1N1) irus, increase the life duration of animals, and normalize the morphological structure of lung tissue comparing to the placebo group. For all the compounds studied, a decrease in the specific mortality of animals (from 20 to 60%) has been shown. The reference drug (oseltamivir phosphate) reduced the mortality of mice by 80%. The benzimidazole derivative 2519 demonstrated the highest indices of protective activity, its use reduced the mortality of animals by 60% and increased their mean day of death by 1.6 days in comparison with the control group. Morphological analysis showed that the activity of derivative 2519 was manifested in the normalization of the morphological structure of lung tissue in the course of influenza pneumonia. On day 5 after infection, the cells of the bronchial epithelium looked intact, in contrast to destroyed cells with numerous viral inclusions in control animals. The foci of inflammation themselves occupied a smaller area compared to the control. At the same time, there was no correlation between the previously obtained data on the virus-inhibiting effect of these compounds in vitro and the data obtained in animals. This suggests that despite the presence of direct antiviral activity detected previously in in vitro experiments, the protective properties of the studied aminobenzimidazoles on animals are caused, in addition to the etiotropic effect, by other pathogenetic factors. In conclusion, amino derivatives of benzimidazole should be considered as compounds that are promising for further development and introduction as an anti-influenza agents.V. V. ZarubaevS. V. VasilievaY. L. EsaulkovaA. V. GarshininaV. M. VeprintsevaA. V. GalochkinaY. S. ProtsakI. V. TeselkinA. S. MorkovnikL. N. DivaevaI. N. LavrentievaSankt-Peterburg : NIIÈM imeni Pasteraarticleinfluenzainfluenza infectionchemotherapybenzimidazole derivativesantiviralsactivity in vivo.Infectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 8, Iss 2, Pp 195-200 (2018)
institution	DOAJ
collection	DOAJ
language	RU
topic	influenza influenza infection chemotherapy benzimidazole derivatives antivirals activity in vivo. Infectious and parasitic diseases RC109-216
spellingShingle	influenza influenza infection chemotherapy benzimidazole derivatives antivirals activity in vivo. Infectious and parasitic diseases RC109-216 V. V. Zarubaev S. V. Vasilieva Y. L. Esaulkova A. V. Garshinina V. M. Veprintseva A. V. Galochkina Y. S. Protsak I. V. Teselkin A. S. Morkovnik L. N. Divaeva I. N. Lavrentieva PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION
description	Influenza is an acute respiratory viral infection, which represents an important health problem. Every year, influenza causes epidemics and pandemics, leading to increase in morbidity and mortality in all regions of the globe. Due to the segmental organization of the genome and low accuracy of its replication, the influenza virus is capable of escaping the host’s immune response (antigenic drift), as well as the selection of drug-resistant variants. This calls for constant monitoring of the sensitivity of viral isolates to antiviral drugs and the development of new etiotropic antiviral agents that have alternative targets and mechanisms of activity. The purpose of this study was to characterize the new aminobenzimidazole derivatives as protective agents in lethal influenza infection in white mice. The efficacy of the compounds was assessed by their ability to reduce specific mortality of animals in the course of lethal influenza pneumonia caused by the influenza A/Puerto Rico/8/34 (H1N1) irus, increase the life duration of animals, and normalize the morphological structure of lung tissue comparing to the placebo group. For all the compounds studied, a decrease in the specific mortality of animals (from 20 to 60%) has been shown. The reference drug (oseltamivir phosphate) reduced the mortality of mice by 80%. The benzimidazole derivative 2519 demonstrated the highest indices of protective activity, its use reduced the mortality of animals by 60% and increased their mean day of death by 1.6 days in comparison with the control group. Morphological analysis showed that the activity of derivative 2519 was manifested in the normalization of the morphological structure of lung tissue in the course of influenza pneumonia. On day 5 after infection, the cells of the bronchial epithelium looked intact, in contrast to destroyed cells with numerous viral inclusions in control animals. The foci of inflammation themselves occupied a smaller area compared to the control. At the same time, there was no correlation between the previously obtained data on the virus-inhibiting effect of these compounds in vitro and the data obtained in animals. This suggests that despite the presence of direct antiviral activity detected previously in in vitro experiments, the protective properties of the studied aminobenzimidazoles on animals are caused, in addition to the etiotropic effect, by other pathogenetic factors. In conclusion, amino derivatives of benzimidazole should be considered as compounds that are promising for further development and introduction as an anti-influenza agents.
format	article
author	V. V. Zarubaev S. V. Vasilieva Y. L. Esaulkova A. V. Garshinina V. M. Veprintseva A. V. Galochkina Y. S. Protsak I. V. Teselkin A. S. Morkovnik L. N. Divaeva I. N. Lavrentieva
author_facet	V. V. Zarubaev S. V. Vasilieva Y. L. Esaulkova A. V. Garshinina V. M. Veprintseva A. V. Galochkina Y. S. Protsak I. V. Teselkin A. S. Morkovnik L. N. Divaeva I. N. Lavrentieva
author_sort	V. V. Zarubaev
title	PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION
title_short	PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION
title_full	PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION
title_fullStr	PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION
title_full_unstemmed	PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION
title_sort	protective activity of novel benzimidazole derivatives at experimental influenza infection
publisher	Sankt-Peterburg : NIIÈM imeni Pastera
publishDate	2018
url	https://doaj.org/article/937dc81199dd4829af7c81afc3581a49
work_keys_str_mv	AT vvzarubaev protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT svvasilieva protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT ylesaulkova protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT avgarshinina protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT vmveprintseva protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT avgalochkina protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT ysprotsak protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT ivteselkin protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT asmorkovnik protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT lndivaeva protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection AT inlavrentieva protectiveactivityofnovelbenzimidazolederivativesatexperimentalinfluenzainfection
_version_	1718417991578681344

PROTECTIVE ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES AT EXPERIMENTAL INFLUENZA INFECTION

Ejemplares similares